Smartleaf Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$3.17K Buy
2025
Q1
$208 Sell
2024
Q4
$9.17K Buy
2024
Q3
$7.92K Buy
2024
Q2
$5.74K Buy